Halozyme Therapeutics
HALO
#2057
Rank
โ‚น653.44 B
Marketcap
โ‚น5,306
Share price
0.28%
Change (1 day)
54.91%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2023 (TTM): โ‚น142.84

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is โ‚น151.20. In 2022 the company made an earnings per share (EPS) of โ‚น128.61 a decrease over its 2021 EPS that were of โ‚น247.66.

EPS history for Halozyme Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น142.8411.07%
2022โ‚น128.61-48.07%
2021โ‚น247.66196.88%
2020โ‚น83.42-292%
2019-โ‚น43.45-9.09%
2018-โ‚น47.79-237.5%
2017โ‚น34.76-149.38%
2016-โ‚น70.39211.54%
2015-โ‚น22.59-52.73%
2014-โ‚น47.79-24.66%
2013-โ‚น63.4348.98%
2012-โ‚น42.58145%
2011-โ‚น17.38-64.29%
2010-โ‚น48.66-17.65%
2009-โ‚น59.099.68%
2008-โ‚น53.8893.75%
2007-โ‚น27.8133.33%
2006-โ‚น20.86-4%
2005-โ‚น21.72-3.85%
2004-โ‚น22.59-13.33%
2003-โ‚น26.0783.59%
2002-โ‚น14.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น16.51-110.92%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น471.79 212.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น444.91 194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น161.63 6.90%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น276.35 82.77%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น1,224 709.50%๐Ÿ‡บ๐Ÿ‡ธ USA